Zenas BioPharma (ZBIO) Exchange Rate Effect (2023 - 2026)
Zenas BioPharma (ZBIO) posted quarterly Exchange Rate Effect of -$311000.0 for Q1 2026, down 498.08% year-over-year from $78125.6 in Q1 2025, and down 2927.27% quarter-over-quarter from $11000.0 in Q4 2025.
Zenas BioPharma (ZBIO) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Zenas BioPharma's Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$311000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 498.08% year-over-year to -$311000.0; the TTM figure through Mar 2026 stood at -$511000.0 (down 840.58% YoY), while the FY2025 annual figure was -$252000.0, down 260.51% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$311000.0, down from $11000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $141000.0 in Q4 2024, with the low at -$311000.0 in Q1 2026.
- The 4-year median for Exchange Rate Effect is -$20500.0 (2024), against an average of -$49300.0.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect surged 262.07% in 2024, then slumped 837.5% in 2025.
- Zenas BioPharma's Exchange Rate Effect stood at -$87000.0 in 2023, then soared by 262.07% to $141000.0 in 2024, then tumbled by 92.2% to $11000.0 in 2025, then tumbled by 2927.27% to -$311000.0 in 2026.
- Business Quant data shows ZBIO's Exchange Rate Effect at -$311000.0 in Q1 2026, $11000.0 in Q4 2025, and $25000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Zenas BioPharma | 1.87 Bn | 748.44 Mn | - | -763,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -763,000.00 |
| Jun 30, 2026 | -763,000.00 |
| Mar 31, 2026 | -311,000.00 |
| Mar 31, 2026 | -311,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | -236,000.00 |
| Jun 30, 2025 | -236,000.00 |
| Mar 31, 2025 | -52,000.00 |
| Mar 31, 2025 | -52,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Sep 30, 2024 | -52,000.00 |
| Sep 30, 2024 | -52,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Mar 31, 2024 | 36,000.00 |